Understand the UK public sector market like never before with Tussell Insight.

Book a demo

Main source

Contracts Finder

The UK has joined the multilateral vaccine procurement initiative - COVAX. The UK has committed £71m to secure purchase rights for vaccine for up to 20% of the total UK population (~13.46M people) through the 'self-financing' arm of the facility (this is separate from the £548 contribution made to COVAX to support vaccine access for lower income countries).
COVAX provides an opportunity to secure access to additional vaccine candidates and further diversify the UK domestic portfolio.

This notice corrects and supersedes a...

Contract detail

Contract status Award notice - awarded
Value
£0 - 71M
Contract can renew No
Contract type Products
Contract sector
  • General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Contract locations
  • East Midlands
  • East Of England
  • London
  • North East
  • Northern Ireland
Contract suitable for SME No
Contract suitable for VCO No
Contract notice published 5 March 2021
Contract tender deadline
7 October 2020
Contract start 8 October 2020
Contract end

8 October 2023

Add contract end date to your calendar

Contract duration
Contract value awarded
£71M
Contract awarded 8 October 2020
Opportunity analysis
Department for Business Energy & Industrial Strategy (BEIS)
Supplier Name City Region Country Sme Awarded Value
The Gavi Alliance Le Grand Saconnex Switzerland No £71M
©2024 Tussell Limited. Site contains public sector information (a) licensed for use by the UK Government under the Open Government License v3.0 and/or (b) from the EU Tenders Electronic Daily website licenced for re-use by the European Commission. This information remains the copyright of the UK Government and European Commission respectively.